Glenmark Life Sciences Ltd - 543322 - Audited Financial Results For The Quarter And Year Ended March 31, 2023

Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer

1014.9000 8.80 (0.87%)

NSE Jun 09, 2025 15:31 PM

Volume: 212.3K

High volume today

Alivus Life Sciences Ltd.

27 Apr 2023

1014.90

0.87%

Result

Glenmark Life Sciences Ltd - 543322 - Audited Financial Results For The Quarter And Year Ended …

BSE India

Audited Financial Results for the quarter and year ended March 31, 2023

More from Alivus Life Sciences Ltd.

Recommended

IPOs This Week: Ganga Bath Fittings set to list; Oswal Pumps and Four New Issues

| 09 Jun 2025, 03:55PM

Market closes higher, Bank of Baroda cuts lending rate by 50 bps to 8.15%

Trendlyne Marketwatch | 09 Jun 2025, 03:54PM

Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public